APLS

NASDAQ · Biotechnology

Apellis Pharmaceuticals Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$41.03

-0.03 (-0.07%)

As of Aug 1, 1:30 AM ET ·

Analyst Consensus

Hold

Analysts

High

Coverage

Buy 8 30%

Hold 19 70%

Sell 0 0%

Price Target

Analyst Price Target -45.1% upside

Low Target $12.93

Average Target $22.54

High Target $29.12

Current Price $41.03

Current
$41.03

Target
$22.54

$12.93 $22.54 avg $29.12

Scenario Analysis

Bear Case

$12.93

-68.5%

Low target

Base Case

$22.54

-45.1%

Avg target

Bull Case

$29.12

+-29.0%

High target

Risk/Reward

0.4x

Unfavorable

Price in Context

52-Week High

$41.14

-0.3% from high

52-Week Low

$16.83

+143.8% from low

50-Day SMA

$23.47

+74.8% vs SMA

200-Day SMA

$22.25

+84.4% vs SMA

RSI (14)

47.9

Neutral

Target vs 52W High

$22.54

-45.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	79%	$257.58	+4.7%
AMGN Amgen Inc	Hold	43	49%	$190.87	-53.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+172.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.6%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-90.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-55.6%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-44.4%
BIIB Biogen Inc	Buy	44	64%	$91.45	-56.0%